e-Article
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'e-Article'
searched 112results | List
1~20
Academic Journal
Rawstron, AC; Kreuzer, K-A; Soosapilla, A; Spacek, M; Stehlikova, O; Gambell, P; McIver-Brown, N; Villamor, N; Psarra, K; Arroz, M
CYTOMETRY PART B-CLINICAL CYTOMETRY. 94(1):121-128
Academic Journal
Rawstron, AC; Ssemaganda, A; de, Tute R; Doughty, C; Newton, D; Vardi, A; Evans, PAS; Stamatopoulos, K; Owen, RG; Lightfoot, T
LANCET HAEMATOLOGY. 4(7):e334-e340
Academic Journal
Owen, RG; Kyle, RA; Stone, MJ; Rawstron, AC; Leblond, V; Merlini, G; Garcia-Sanz, R; Ocio, EM; Morra, E; Morel, P
BRITISH JOURNAL OF HAEMATOLOGY. 160(2):171-176
Academic Journal
ACR Open Rheumatol
ACR Open Rheumatology, Vol 4, Iss 8, Pp 689-699 (2022)
ACR Open Rheumatology, Vol 4, Iss 8, Pp 689-699 (2022)
Academic Journal
Md Yusof, MY; Vital, EM; McElvenny, DM; Hensor, EMA; Das, S; Dass, S; Rawstron, AC; Buch, MH; Emery, P; Savic, S
Md Yusof, M Y, Vital, E M, McElvenny, D M, Hensor, E M A, Das, S, Dass, S, Rawstron, A C, Buch, M H, Emery, P & Savic, S 2019, 'Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases', Arthritis & rheumatology (Hoboken, N.J.), vol. 71, no. 11, pp. 1812-1823. https://doi.org/10.1002/art.40937
Academic Journal
Owen, RG; Child, JA; Jackson, GH; Davies, FE; Drayson, MT; Ross, FM; Gregory, WM; Szubert, AJ; Bell, SE; Heatley, F; Navarro-Coy, N; Rawstron, AC; Morgan, GH
In Clinical Lymphoma & Myeloma February 2009 9 Supplement 1:S84-S85
Academic Journal
Owen, RG; Morgan, GJ; Jackson, H; Davies, FE; Drayson, MT; Ross, FM; Navarro-Coy, N; Gregory, WM; Szubert, AJ; Rawstron, AC; Bell, SE; Heatley, F; Child, JA
In Clinical Lymphoma & Myeloma February 2009 9 Supplement 1:S85-S85
Academic Journal
Owen, RG; Rawstron, AC; Drayson, MT; Davies, FE; Jackson, GH; Ross, FM; Gregory, WM; Szubert, AJ; Bell, SE; Navarro-Coy, N; Heatley, F; Morgan, GJ; Child, AJ
In Clinical Lymphoma & Myeloma February 2009 9 Supplement 1:S76-S76
Academic Journal
Howard, DR; Munir, T; McParland, L; Rawstron, AC; Milligan, D; Schuh, A; Hockaday, A; Allsup, DJ; Marshall, S; Duncombe, AS; O’Dwyer, JL; Smith, AF; Longo, R; Varghese, A; Hillmen, P
Leukemia. 31:2416-2425
Academic Journal
Varghese, A; Howard, DR; Pocock, C; Rawstron, AC; Follows, G; McCarthy, H; Dearden, C; Fegan, C; Milligan, D; Smith, AF; Gregory, WM; Hillmen, P
British Journal of Haematology. 176:573-582
Academic Journal
Kwok, M; Rawstron, AC; Varghese, A; Evans, PAS; O'Connor, SJM; Doughty, C; Newton, DJ; Moreton, P; Hillmen, P
Blood. 128:2770-2773
Academic Journal
Oncogenesis
Academic Journal
Rawstron, AC; Fazi, C; Agathangelidis, A; Villamor, N; Letestu, R; Nomdedeu, J; Palacio, C; Stehlikova, O; Kreuzer, K-A; Liptrot, S; O'Brien, D; de Tute, RM; Marinov, I; Hauwel, M; Spacek, M; Dobber, J; Kater, AP; Gambell, P; Soosapilla, A; Lozanski, G; Brachtl, G; Lin, K; Boysen, J; Hanson, C; Jorgensen, JL; Stetler-Stevenson, M; Yuan, C; Broome, HE; Rassenti, L; Craig, F; Delgado, J; Moreno, C; Bosch, F; Egle, A; Doubek, M; Pospisilova, S; Mulligan, S; Westerman, D; Sanders, CM; Emerson, R; Robins, HS; Kirsch, I; Shanafelt, T; Pettitt, A; Kipps, TJ; Wierda, WG; Cymbalista, F; Hallek, M; Hillmen, P; Montserrat, E; Ghia, P; CLL, ERIC European Res Initiative
Leukemia
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
instname
Leukemia, vol 30, iss 4
LEUKEMIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
instname
Leukemia, vol 30, iss 4
Academic Journal
Stetler-Stevenson, M; Paiva, B; Stoolman, L; Lin, P; Jorgensen, JL; Orfao, A; Dongen, Jacques; Rawstron, AC
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Academic Journal
Dalemari, Crowther-Swanepoel; Tanguy, Corre; Amy, Lloyd; Gianluca, Gaidano; Bianca, Olver; Fiona L, Bennett; Chi, Doughty; Daniela, Toniolo; Federico, Caligaris-Cappio; Federico, Calligaris-Cappio; Paolo, Ghia; Davide, Rossi; Andy C, Rawstron; Daniel, Catovsky; Richard S, Houlston
Blood. 116:5957-5960
Academic Journal
Annals of the Rheumatic Diseases. 78:1069-1070
Academic Journal
Collett, L; Howard, DR; Munir, T; McParland, L; Oughton, JB; Rawstron, AC; Hockaday, A; Dimbleby, C; Phillips, D; McMahon, K; Hulme, C; Allsup, D; Bloor, A; Hillmen, P
Trials
Collett, L, Howard, D R, Munir, T, McParland, L, Oughton, J B, Rawstron, A C, Hockaday, A, Dimbleby, C, Phillips, D, McMahon, K, Hulme, C, Allsup, D, Bloor, A & Hillmen, P 2017, 'Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial) : Study protocol for a phase III randomised controlled trial', Trials, vol. 18, no. 1, 387. https://doi.org/10.1186/s13063-017-2138-6
Collett, L, Howard, D R, Munir, T, McParland, L, Oughton, J B, Rawstron, A C, Hockaday, A, Dimbleby, C, Phillips, D, McMahon, K, Hulme, C, Allsup, D, Bloor, A & Hillmen, P 2017, 'Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial) : Study protocol for a phase III randomised controlled trial', Trials, vol. 18, no. 1, 387. https://doi.org/10.1186/s13063-017-2138-6
Academic Journal
Oughton, JB; Collett, L; Howard, DR; Hockaday, A; Munir, T; McMahon, K; McParland, L; Dimbleby, C; Phillips, D; Rawstron, AC; Hillmen, P
Trials
Trials, Vol 18, Iss 1, Pp 1-12 (2017)
Oughton, JB, Collett, L, Howard, D R, Hockaday, A, Munir, T, McMahon, K, McParland, L, Dimbleby, C, Phillips, D, Rawstron, A C & Hillmen, P 2017, ' GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial : study protocol for a phase II/III randomised controlled trial. ', Trials, vol. 18, 353 . https://doi.org/10.1186/s13063-017-2107-0
Trials, Vol 18, Iss 1, Pp 1-12 (2017)
Oughton, JB, Collett, L, Howard, D R, Hockaday, A, Munir, T, McMahon, K, McParland, L, Dimbleby, C, Phillips, D, Rawstron, A C & Hillmen, P 2017, ' GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial : study protocol for a phase II/III randomised controlled trial. ', Trials, vol. 18, 353 . https://doi.org/10.1186/s13063-017-2107-0
Academic Journal
Howard, DR; Munir, T; Hockaday, AM; Rawstron, AC; Collett, L; Oughton, JB; Allsup, D; Bloor, A; Phillips, D; Hillmen, P
Trials
Howard, DR, Munir, T, Hockaday, A,Rawstron, AC , Collett, L, Oughton, JB, Allsup, D, Bloor, A, Phillips, D & Hillmen, P 2016, ' Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial. ', Trials, vol. 17, 456 (2016) . https://doi.org/10.1186/s13063-016-1581-0
Howard, D R, Munir, T, Hockaday, A, Rawstron, A C, Collett, L, Oughton, J B, Allsup, D, Bloor, A, Phillips, D & Hillmen, P 2016, 'Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial : Study protocol for a phase II randomised controlled trial', Trials, vol. 17, no. 1, 456. https://doi.org/10.1186/s13063-016-1581-0
Howard, DR, Munir, T, Hockaday, A,
Howard, D R, Munir, T, Hockaday, A, Rawstron, A C, Collett, L, Oughton, J B, Allsup, D, Bloor, A, Phillips, D & Hillmen, P 2016, 'Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial : Study protocol for a phase II randomised controlled trial', Trials, vol. 17, no. 1, 456. https://doi.org/10.1186/s13063-016-1581-0
Refining the search results
Facets
[AR] Rawstron, AC
Publication year
-
Database provider
Title
Publisher
자료유형(Source Type)
Subject
Language